This is a preview of subscription content, log in via an institution to check access.
Notes
P1025 and Surveillance Monitoring for ART Toxicities (SMARTT)
Reference
Rough K, et al. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine. New England Journal of Medicine 378: 1593-1603, No. 17, 26 Apr 2018. Available from: URL: http://doi.org/10.1056/NEJMoa1701666
Rights and permissions
About this article
Cite this article
Emtricitabine/tenofovir does not increase adverse birth outcomes. Reactions Weekly 1701, 10 (2018). https://doi.org/10.1007/s40278-018-45842-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-45842-7